A polymorphism in FASL is associated with rituximab response in follicular lymphoma patients

MeSH terms

• Antineoplastic Agents, Immunological / administration & dosage
• Antineoplastic Agents, Immunological / therapeutic use*
• Antineoplastic Combined Chemotherapy Protocols / therapeutic use
• Fas Ligand Protein / genetics*
• Female
• Humans
• Lymphoma, Follicular / drug therapy*
• Lymphoma, Follicular / genetics*
• Lymphoma, Follicular / pathology
• Male
• Middle Aged
• Pharmacogenomic Testing
• Polymorphism, Single Nucleotide
• Rituximab / administration & dosage
• Rituximab / therapeutic use*